Clinical Trial Update: Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA)

View source ↗

Summary

Clinical trial update describing predictors of level of response to Cladribine tablets in clinical practice for multiple sclerosis (CLODINA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Cladribine tablets (cladribine)

Snippet

Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Conditions: Multiple Sclerosis | Status: ACTIVE_NOT_RECRUITING